Aptorum Group Ltd Class A (APM)

NASDAQ
1.490
+0.011(+0.71%)
  • Volume:
    35,642
  • Day's Range:
    1.490 - 1.560
  • 52 wk Range:
    0.855 - 2.940

APM Overview

Prev. Close
1.48
Day's Range
1.49-1.56
Revenue
1.54M
Open
1.49
52 wk Range
0.855-2.94
EPS
-0.715
Volume
35,642
Market Cap
54.27M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
115,759
P/E Ratio
-1.99
Beta
0.026
1-Year Change
-41.73%
Shares Outstanding
35,703,257
Next Earnings Date
-
What is your sentiment on Aptorum A?
or
Vote to see community's results!

Aptorum Group Ltd Class A News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Aptorum Group Ltd Class A Company Profile

Aptorum Group Ltd Class A Company Profile

Employees
26

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellNeutralSell
Technical IndicatorsStrong SellStrong SellStrong SellBuyStrong Sell
SummaryStrong SellStrong SellStrong SellNeutralStrong Sell
  • Added by 1,75. I waiting a new rally to the 3 and more…
    0
    • %86 premarket? another meme stock?
      0
      • Sometimes need to risk 6 in order to get 3. Not sure if it's healthy.
        0
        • good bye enjoy your day
          0
          • captain start flying again
            0
            • Captain --- Cabincrew get ready for Landing
              0
              • guys are you think this will spike more
                0
                • Yes
                  0
                • If you are in loss cut your losses before its too late.
                  0
              • Im trying to say i am ok..... it will be alright.
                0
                • Oh ye~
                  0
                  • Just buy mohamed. 1000 procent more today
                    6
                    • Hyva aija
                      0